Cancer and Vitamin C, new studies and new discoveries
Published on 10/3/2014
In the 1970s, more than a few people considered vitamin C an "unorthodox" remedy against numerous forms of cancer.
Only more recently have researchers understood that the effects of vitamin C on cancer cells occur only with intravenous administration and not by the oral route.
The most recent research on the subject was conducted by the University of Kansas (USA), which for 5 years monitored, in 27 patients, the course of ovarian cancer diagnosed at stage 3 or 4.
Some of the 27 patients, alongside traditional chemotherapy with paclitaxel or carboplatin, were given doses of vitamin C that can only be administered intravenously.
It is too early to declare victory. The data currently held by the Kansas University Medical Centre go only as far as demonstrating that in the patients treated with the massive dose of vitamin C, the toxic effects of chemotherapy are more limited.
The "anti-cancer" effects — that is, the ability of Vitamin C to kill cancer cells without inducing toxic effects on the body — have to date been demonstrated, in part, only in laboratory animals.